Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Recurrent Miscarriage and Implantation Failure of Unknown Cause Studied by a Panel of Thrombophilia Conditions: Increased Frequency of FXIII Val34Leu Polymorphism

Authors
Maria Diaz-Nuñez 1
Aintzane Rabanal 1
Antonia Expósito 1
Marcos Ferrando 2
Fernando Quintana 2
Jose Soria 3
Roberto Matorras 4
1 Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain
2 IVI Bilbao, Bizkaia, Spain
3 Unit of Genomics of Complex Diseases, Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain
4 Human Reproduction Unit, Cruces University Hospital, Biocruces, Barakaldo, Spain; IVI Bilbao, Bizkaia, Spain
Abstract
Background: The role of acquired thrombophilia has been accepted as an etiology of recurrent miscarriage (RM); however, the contribution of specific inherited thrombophilic genes to this disorder has remained controversial. An increased incidence of RM has been suggested in women with inherited thrombophilia. Methods: In this prospective study, assisted women with RM or repeated implant failure (RIF) were subjected to Thromboincode analysis, in order to identify 12 genetic variants for Factor V Leiden, Factor V Hong Kong, Factor V Cambridge, FII, FXIII, FXII, and A1 carriers. Patients included in this study were separated in RM cases (n=43), RIF cases (n=36) and RIF+RM (n=76). As a control group, patients undergoing IVF treatment (n=34) were used and a previously described 249 cases population as a representative sample of Spanish population were selected. Level of statistical significance was p<0.05 and groups were compared by Fisher test, except for age that was compared by t-test. Results: Regarding FXIII, higher values were observed in RM (69.76%), RIF (70%) and in RM+RIF (68.42%) group when compared with our control group (52.94%) and general Spanish population (56.5%), but these differences were statistically significant only in RIF group (p=0.043, p=0.01). Conclusion: Concerning our findings, both RM and RIF patients had a very similar panel of thrombophilia polymorphisms, suggesting that, in both, thrombophilia might have an important contribution. High frequency of Val34Leu polymorphism in RM/RIF presumably speaks in favor of a multifactorial RM genesis, wherean altered thrombophilia status plays a role.
Keywords
Factor XII
Implant failure
IVF
Miscarriage
Thrombophilia
  1. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216-22.
  2. Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368(9535):601-11.
  3. Rubio C, Pehlivan T, Rodrigo L, Simón C, Remohí J, Pellicer A. Embryo aneuploidy screening for unexplained recurrent miscarriage: a minireview. Am J Reprod Immunol. 2005;53(4):159-65.
  4. Bradley LA, Palomaki GR, Bienstock J, Varga E, Scott JA. Can factor V leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in impoved pregnancy outcomes): Results from a targeted evidence-based review. Genet Med. 2012;14(1):39-50.
  5. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006;55(5):360-8.
  6. Dawood F, Farquharson R, Quenby S, Toh CH. Acquired activated protein C resistance may be a risk factor for recurrent fetal loss. Fertil. Steril. 2003;80(3):649-50.
  7. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361:901-8.
  8. McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol. 2012;24(4):229-34.
  9. Li J, Wu H, Chen Y, Wu H, Xu H, Li L. Genetic association between FXIII and β-fibrinogen genes and women with recurrent spontaneous abortion: a meta- analysis. J Assist Reprod Genet. 2015;32(5):817-25.
  10. Christiansen OB, Nielsen HS, Kolte AM. Future directions of failed implantation and recurrent miscarriage research. Reprod Biomed Online. 2006;13(1):71-83.
  11. Bellver J, Soares SR, Alvarez C, Muñoz E, Ramírez A, Rubio C, et al. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum. Reprod. 2008;23(2):278-84.
  12. Timeva T, Shterev A, Kyurkchiev S. Recurrent implantation failure: the role of the endometrium. J Reprod Infertil. 2014;15(4):173-83.
  13. Azem F, Many A, Ben Ami I, Yovel I, Amit A, Lessing JB, et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19(2):368-70.
  14. Grandone E, Colaizzo D, Lo Bue A, Checola MG, Cittadini E, Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril. 2001;76(1):201-2.
  15. Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006;21(10):2694-8.
  16. Geva E, Amit A, Lerner-Geva L, Azem F, Yovel I, Lessing JB. Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod. 1995;10(10):2560-3.
  17. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update. 2008;14(6):623-45.
  18. Martinelli I, Battaglioli T, Mannucci PM. Screening of thrombophilia in women with failure of embryo implantation: far from being recommended. Haematologica. 2003;88(12):ELT36.
  19. Simur A, Ozdemir S, Acar H, Colakoğlu MC, Görkemli H, Balci O, et al. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol Obstet Invest. 2009;67(2):109-12.
  20. Soria JM, Morange PE, Vila J, Souto JC, Moyano M, Trégouët DA, et al. Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc. 2014;3(5):e00106.
  21. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol. 2006;56(4):230-6.
  22. Altman DG. Practical statistics for medical research. 1st ed. London: Chapman and Hall; 1991. 624 p.
  23. Pagano M, Gauvreau K. Principles of biostatistics. 2nd ed. Belmont, CA: Chapman and Hall; 2000. 584 p.
  24. Deeks, J.J., Higgins, J.P.T., 2010. Statistical algorithms in review manager 5. Statistical methods group of the cochrane collaboration. August 2010. Available from https://training.cochrane.org/hand-book/statistical-methods-revman5.
  25. de Haan HG, Bezemer ID, Doggen CJ, Le Cessie S, Reitsma PH, Arellano AR, et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood. 2012;120(3):656-63.
  26. Corral J, Hernández-Espinosa D, Soria JM, Gonzalez-Conejero R, Ordonez A, Gonzalez-Porras JR, et al. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood. 2007;109(10):4258-63.
  27. Corral J, Gonzalez-Conejero R, Soria JM, González-Porras JR, Pérez-Ceballos E, Lecumberri R, et al. A nonsensepolymorphism in the protein Z-dependent proteaseinhibitor increases the risk for venous thrombosis. Blood. 2006;108(1):177-83.
  28. Dennis J, Johnson CY, Adediran AS, de Andrade M, Heit JA, Morange PE, et al. The endothelialprotein C receptor (PROCR) Ser219Gly variant andrisk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. Blood. 2012;119(10):2392-400.
  29. Walch K, Riener EK, Tempfer CB, Endler G, Huber JC, Unfried G. The C46T polymorphism of the coagulation factor XII gene and idiopathic recurrent miscarriage. BJOG. 2005;112(10):1434-6.
  30. Bagoly Z, Koncz Z, Hársfalvi J, Muszbek L. Factor XIII, clot structure, thrombosis. Thromb Res. 2012;129(3):382-7.
  31. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. semin. Thromb Hemost. 2009;35(4):426-38.
  32. Muszbek L, Bagoly Z, Cairo A, Peyvandi F. Novel aspects of factor XIII deficiency. Curr Opin Hematol. 2011;18(5):366-72.
  33. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96(3):988-95.
  34. Wartiovaara U, Mikkola H, Szôke G, Haramura G, Kárpáti L, Balogh I, et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost. 2000;84(4):595-600.
  35. Kohler HP, Ariëns RA, Whitaker P, Grant PJ. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost. 1998;80(4):704.
  36. Suzuki K, Henke J, Iwata M, Henke L, Tsuji H, Fukunaga T, et al. Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene. Hum Genet. 1996;98(4):393-5.
  37. Lim BC, Ariëns RA, Carter AM, Weisel JW, Grant PJ. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet. 2003;361(9367):1424-31.
  38. Vokó Z, Bereczky Z, Katona E, Adány R, Muszbek L. Factor XIII Val34Leu variant protects against coronary artery disease. a meta-analysis. Thromb Haemost. 2007;97(3):458-63.
  39. López Ramírez Y, Vivenes M, Miller A, Pulido A, López Mora J, Arocha-Piñango CL, et al. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage. Clin Chim Acta. 2006;374(1-2):69-74.
  40. Bagheri M, Rad IA, Omrani MD, Nanbaksh F. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion. Syst Biol Reprod Med. 2011;57(5):261-4.
  41. Barbosa HC, Carvalho EC, Barini R, Siqueira LH, Costa DS, Annichino-Bizzacchi JM. Tyr204Phe and Val34Leu polymorphisms in two Brazilian ethnic groups and in patients with recurrent miscarriages. Fertil Steril. 2004;82(5):1455-7.
Journal of Reproduction & Infertility
Volume 20, Issue 2
Spring 2019
Pages 76-82